How to Fill Out Form SSA-4814 (w/Examples) + FAQs

Form SSA-4814 is the Social Security Administration’s Medical Report on Adult with Allegation of Human Immunodeficiency Virus (HIV) Infection, and a treating physician must complete it to document the clinical evidence that supports a disability claim based on HIV. The form translates a claimant’s medical record into the structured proof that Disability Determination Services (DDS) needs to apply Listing 14.11 of the SSA Blue Book.

If the form is incomplete, illegible, or missing lab values, DDS will issue a request for more evidence under 20 CFR 404.1512, which delays the claim by months and can trigger an outright denial for insufficient evidence. According to the SSA’s most recent Annual Statistical Report on the SSDI Program, only about 35% of initial disability claims are approved, and immune-system claims under Listing 14.00 fall below that average when the medical evidence is thin.

This guide walks through every line of SSA-4814, the federal rules behind it, named-person examples, common mistakes, scenario tables, and a full FAQ block at the end.

  • 🩺 How each item on SSA-4814 maps to the criteria in Listing 14.11
  • 📋 Exactly what lab values, CD4 counts, and viral loads to attach
  • ⚖️ The federal regulations and POMS sections that govern the form
  • 🧑‍⚕️ Real claimant scenarios showing approvals, denials, and remands
  • 🚫 The seven costliest mistakes that sink HIV disability claims

What Is Form SSA-4814?

Form SSA-4814 is a structured medical questionnaire issued by the Social Security Administration and described in the agency’s POMS DI 22517.005 as the preferred vehicle for capturing HIV-specific medical evidence from a treating source. The form exists because HIV disability claims require clinical detail that a generic medical record rarely organizes in one place, including CD4 counts, viral load trajectories, opportunistic infections, and functional limitations. By forcing the physician to answer SSA’s specific questions, the form aligns the medical record with the legal standards in Listing 14.11 HIV Infection and the functional criteria in 14.00H.

The plain-English purpose of SSA-4814 is to give DDS a single document that answers, “Does this claimant meet a Blue Book listing for HIV, or does HIV plus other impairments equal a listing?” The consequence of submitting a claim without SSA-4814 is that DDS will either send the form to the treating doctor directly under 20 CFR 404.1517 or schedule a consultative exam at taxpayer expense, both of which add weeks to the timeline. A common misconception is that office notes alone are enough; in practice, examiners trained under the Disability Examiner’s Handbook prefer the structured form because it eliminates guesswork.

A real example: Marcus, a 47-year-old warehouse worker in Atlanta, filed for SSDI after a Stage 3 HIV diagnosis. His attorney submitted SSA-4814 with CD4 nadir of 42, current viral load of 89,000 copies/mL, and documented PCP pneumonia, and DDS approved the claim under Listing 14.11A within 90 days, well below the national average of 7.4 months reported in the SSA’s FY 2024 Performance Plan.

Legal Authority Behind SSA-4814

The form draws its authority from Section 223(d) of the Social Security Act, which defines disability, and from the implementing regulations at 20 CFR 404.1513 governing categories of medical evidence. SSA’s binding sub-regulatory guidance lives in the POMS DI 24580 series on evaluating immune-system disorders and in SSR 23-1p on evaluating symptoms.

The consequence of ignoring these authorities is harsh because DDS must apply them whether or not the claimant cites them, and a physician who skips the lab-value sections forces DDS to rule under the lower-weight “other medical evidence” category. A common misconception is that a doctor’s narrative letter outranks the form; under 20 CFR 404.1520c, the persuasiveness of any opinion turns on supportability and consistency, both of which the structured form maximizes.

Where SSA-4814 Fits in the Claim Process

The form enters the file at the initial application stage, when the claimant lists treating sources on Form SSA-3368 and signs the Form SSA-827 medical release. DDS then mails SSA-4814 to the HIV specialist, infectious-disease clinic, or Ryan White program physician, and the doctor returns it directly to the state agency. If the case advances to reconsideration or hearing, the form remains in the certified electronic file and is reviewed again under the rules in the HALLEX manual.

The consequence of a missing form at the hearing level is that the Administrative Law Judge may keep the record open for post-hearing evidence, but only if counsel objects on the record. A real scenario: Priscilla, a 39-year-old teacher in Phoenix, won at hearing because her attorney submitted SSA-4814 five days before the hearing under the five-day rule at 20 CFR 404.935.

Who Needs to Complete Form SSA-4814

The treating physician with the longest and deepest relationship to the claimant’s HIV care is the preferred source, and SSA’s regulation at 20 CFR 404.1502 defines an “acceptable medical source” to include licensed physicians, advanced practice registered nurses, and physician assistants for claims filed on or after March 27, 2017. The form should not be completed by the claimant, by a family member, or by a non-medical case manager, because DDS will give such submissions little or no weight under 20 CFR 404.1520c(c).

The plain-English rule is that whoever signs the form must have personally examined the claimant and reviewed the labs they cite. The consequence of a non-treating signature is rejection of the form as evidence and a possible referral for consultative examination under 20 CFR 404.1519a. A common misconception is that a nurse practitioner cannot sign; under the 2017 rule change, an APRN can sign, but the supervising physician’s co-signature still strengthens supportability.

A real example: Devon, a 52-year-old chef in Brooklyn, had his initial claim denied because his primary care PA completed the form without citing the infectious-disease specialist’s CD4 trend; on reconsideration, the ID doctor re-completed SSA-4814 and the claim was approved under Listing 14.11G.

Step-by-Step Instructions for Each Item

The form is organized into ten numbered items, and every box matters because DDS examiners use a checklist that mirrors the listing criteria. Below is a walk-through of every line, the consequence of leaving it blank, and how to answer it well, all consistent with the guidance in POMS DI 22517.010.

Item 1: Claimant Identification

Enter the claimant’s full legal name, Social Security number, and date of birth exactly as they appear on the application. The plain-English reason is that any mismatch can cause the form to be associated with the wrong electronic folder under SSA’s eDIB system described in POMS DI 81010.020. The consequence of a typo is that DDS may treat the form as unsolicited evidence and delay processing while it is re-routed.

A common misconception is that nicknames are acceptable. They are not, because the agency’s matching algorithm flags name discrepancies. Yolanda Marie Reyes should be written that way and never as Yoli Reyes, even if her chart uses the nickname.

Item 2: Source Identification and Treating Relationship

Provide the physician’s full name, NPI number, specialty, address, phone, and the dates of the first and most recent visits. The longer and more specialized the relationship, the more weight DDS gives the opinion under the supportability and consistency factors of 20 CFR 404.1520c(c). The consequence of an undated treating relationship is that the examiner cannot tell whether the source has longitudinal knowledge.

A real scenario: Antoine, a 44-year-old electrician, listed an urgent care doctor he saw twice; DDS gave that opinion little weight and approved the claim only after his Ryan White clinic doctor of nine years completed a new form.

Item 3: HIV Diagnosis and Documentation

Document the method of HIV diagnosis, including the positive ELISA, Western blot, or HIV-1/2 antigen-antibody test, and the date of diagnosis. SSA requires laboratory confirmation under Listing 14.00F1 because clinical impression alone is not enough. The consequence of skipping the confirmatory test result is that DDS will not even reach the listing criteria.

A common misconception is that a self-reported diagnosis is enough if the patient is on antiretrovirals. It is not, and the form should attach the original positive lab. Camille, a 36-year-old nurse, attached her 2019 confirmatory Western blot, and her claim moved straight to evaluation under 14.11.

Item 4: CD4 Count and Viral Load History

List every CD4 count and viral load with dates, ideally going back at least 12 months. CD4 nadir under 50 cells/mm³ is one pathway to meet Listing 14.11G, and a viral load that remains detectable despite adherence supports severity. The consequence of listing only the most recent count is that DDS cannot evaluate trajectory, which often determines the outcome.

A real example: Rosa, a 41-year-old hotel housekeeper, had a single recent CD4 of 220 but a nadir of 38 in 2022; the trajectory data in Item 4 unlocked Listing 14.11G approval.

Item 5: Opportunistic Infections and Listed Conditions

Check every opportunistic infection or HIV-associated condition the claimant has experienced, including PCP, candidiasis of the esophagus, cryptococcosis, toxoplasmosis, CMV, Kaposi’s sarcoma, primary CNS lymphoma, HIV encephalopathy, HIV wasting syndrome, and multicentric Castleman disease. Each maps to a sub-paragraph of Listing 14.11A through 14.11F. The consequence of omitting a documented infection is that the claimant loses the most direct path to a listing-level finding.

A common misconception is that resolved infections do not count. Under the listing, a documented historical PCP episode confirmed by bronchoalveolar lavage still satisfies 14.11A. Jamal, a 49-year-old bus driver, was approved on a 2021 PCP episode even though he had been stable for two years.

Item 6: Functional Limitations Under 14.00H

Describe limitations in activities of daily living, social functioning, and the ability to complete tasks in a timely manner due to fatigue or cognitive impairment, which is the route under Listing 14.11I. The physician must rate the limitation as marked in at least one of the three areas. The consequence of vague language like “moderately limited” is that DDS cannot find a marked limitation and will deny under the listing.

A real scenario: Helen, a 58-year-old paralegal, was approved when her doctor wrote that her HIV-related fatigue caused marked limitation in completing tasks, citing a 12-month attendance log from her employer.

Item 7: Treatment, Medications, and Side Effects

List the antiretroviral regimen, dosages, adherence, and side effects such as peripheral neuropathy, lipodystrophy, or nausea. SSA evaluates side effects under SSR 16-3p and SSR 23-1p when assessing residual functional capacity. The consequence of omitting side effects is a higher RFC and a likely denial at step five.

A common misconception is that being on an effective regimen disqualifies the claimant. It does not, because functional limitations and side effects can still preclude work. Tyrese, a 45-year-old roofer, was approved despite an undetectable viral load because dolutegravir-related insomnia and neuropathy limited him to sedentary work he could not perform given his vocational profile under the Medical-Vocational Guidelines.

Item 8: Co-Occurring Impairments

Document hepatitis B or C co-infection, depression, anxiety, neurocognitive disorder, cardiovascular disease, or any other impairment. Under 20 CFR 404.1523, SSA must consider the combined effect of all impairments. The consequence of leaving this blank is that the claim is evaluated only on HIV, missing the medically equivalent path under 20 CFR 404.1526.

A real example: Naomi, a 50-year-old retail manager, had moderate HIV but severe major depressive disorder; the combination was found medically equivalent to a listing.

Item 9: Prognosis and Expected Duration

State whether the impairment has lasted or is expected to last at least 12 continuous months, the durational requirement at 20 CFR 404.1509. HIV is by definition lifelong, so the answer is almost always yes, but the form must explicitly say so.

A common misconception is that the durational box is optional. It is not, and a blank duration is a top reason for technical denials.

Item 10: Physician Certification and Signature

The physician must sign, date, and provide their license number and contact information. An unsigned form is not evidence under 20 CFR 404.1513(a). The consequence of a missing signature is a return-for-completion notice that adds weeks.

A real scenario: Brian, a 53-year-old machinist, lost three months because his doctor’s e-signature stamp was rejected as unauthenticated; an ink signature on a re-issued form fixed it.

Three Common Scenarios With Outcomes

The scenarios below reflect the most frequent fact patterns DDS examiners report when adjudicating HIV claims, drawing on the SSA’s Office of Disability Adjudication and Review data.

Scenario A: Strong Listing Match

Claimant Action Adjudication Result
Attaches SSA-4814 with CD4 nadir of 38 and documented PCP Approved at initial under Listing 14.11A within 90 days
Lists infectious-disease specialist with 6-year relationship Opinion found highly persuasive under 20 CFR 404.1520c
Documents marked limitation in completing tasks Alternative path under 14.11I supports approval

Scenario B: Functional Path Without Listing-Level Labs

Claimant Action Adjudication Result
CD4 stable at 350, viral load undetectable Does not meet 14.11G on labs alone
Doctor documents marked fatigue and cognitive slowing Meets 14.11I functional criteria
Side effects of efavirenz documented in Item 7 RFC limited to sedentary, grids direct approval

Scenario C: Denial for Incomplete Form

Claimant Action Adjudication Result
SSA-4814 missing Items 4 and 6 DDS schedules consultative exam, adds 60 days
CE doctor finds no marked functional limitation Initial denial issued
Reconsideration with complete form and ID specialist signature Approval at reconsideration under 14.11G

Mistakes to Avoid

Disability practitioners and SSA examiners report the same recurring errors on SSA-4814, and each one carries a concrete cost.

  • Submitting the form without attaching the confirmatory HIV lab, which violates the documentation rule in Listing 14.00F1 and forces DDS to delay the case.
  • Listing only the most recent CD4 count, which hides the nadir that often unlocks Listing 14.11G and leads to a denial that could have been an approval.
  • Using vague functional language such as “limited” instead of the regulatory term marked, which prevents DDS from finding the listing-level severity at 14.11I.
  • Allowing a non-treating provider to sign, which lowers persuasiveness under 20 CFR 404.1520c and triggers consultative exams.
  • Ignoring co-occurring impairments like hepatitis C, depression, or neurocognitive disorder, which removes the medical-equivalence pathway at 20 CFR 404.1526.
  • Skipping medication side effects, which inflates the residual functional capacity and pushes claims to a step-five denial under the Medical-Vocational Guidelines.
  • Leaving the duration box blank, which causes a technical denial even when the medical evidence is otherwise strong.
  • Using an unauthenticated electronic signature, which DDS rejects under SSA’s signature policy in POMS GN 00201.015.
  • Failing to date every lab value, which makes trajectory analysis impossible and weakens supportability.
  • Submitting the form months after the application without a cover letter, which can cause it to be filed as unsolicited evidence outside the active workflow.

Do’s and Don’ts

The do’s and don’ts below come from the practice guidance published by the National Organization of Social Security Claimants’ Representatives and from SSA’s own Disability Professionals page.

Do’s

  • Do request the form early so the doctor has time to pull labs spanning the full 12-month period required by 20 CFR 404.1509, because rushed forms are less complete.
  • Do attach a cover letter that cross-references each item to the listing criterion it supports, since examiners value clarity that mirrors their own checklist.
  • Do include the SSA-827 release with the form, because providers often will not release records without it under HIPAA’s 45 CFR 164.508.
  • Do use the regulatory word marked when functional limitations rise to listing level, because that is the precise term the listing requires.
  • Do submit updates if labs change before the decision, since 20 CFR 404.1512(a) imposes a duty to inform.

Don’ts

  • Don’t allow the claimant to fill in any medical content, because that destroys the form’s value as treating-source evidence under 20 CFR 404.1502.
  • Don’t omit resolved opportunistic infections, because Listing 14.11A through 14.11F count historical episodes when properly documented.
  • Don’t rely on an undated narrative letter, because supportability under 20 CFR 404.1520c(c)(1) requires objective findings tied to dates.
  • Don’t ignore mental health symptoms, because depression and HIV-associated neurocognitive disorder routinely drive medical equivalence findings.
  • Don’t submit the form without verifying the NPI and license, because clerical errors trigger return-for-completion notices that can cost the case at deadline time.

Pros and Cons of Using SSA-4814

Even though the form is the preferred vehicle, it has trade-offs that experienced advocates weigh against alternatives like a custom medical source statement.

Pros

  • The structured fields directly mirror Listing 14.11, which raises the consistency factor under 20 CFR 404.1520c(c)(2).
  • Examiners are trained to find information quickly on the form, which speeds adjudication and reduces consultative exam referrals.
  • The form prompts the physician to address every listing element, which prevents accidental omissions.
  • It produces a document that survives appeal because Administrative Law Judges accept the same form under HALLEX I-2-5-14.
  • It standardizes evidence across providers, which is useful when multiple specialists treat the claimant.

Cons

  • The form’s compressed boxes can fail to capture nuance, so a supplemental narrative is often needed.
  • Some providers refuse to complete agency forms, which forces the use of a custom medical source statement.
  • The form does not include space for genotype resistance testing, which can matter in advanced disease.
  • Updating the form mid-claim requires a fresh signature, which adds administrative friction.
  • It addresses HIV but not co-occurring impairments in depth, so additional forms may be needed for mental health or hepatitis.

Federal Versus State Nuances

Federal law sets the substantive standard, but each state’s Disability Determination Services agency processes the form, and DDS practices vary in turnaround and consultative exam usage. Under 20 CFR 404.1503, states must follow SSA standards, but processing times in 2025 ranged from under five months in some Midwest states to over ten months in California and New Jersey, according to the SSA Operational Data.

The plain-English consequence is that the same SSA-4814 may move quickly in one state and slowly in another, and counsel should track state DDS performance through the SSA’s State Agency Operations Reports. A common misconception is that filing in a different state speeds the case; the rule is that DDS jurisdiction follows the claimant’s residence at the time of filing.

A real scenario: Olivia, a 47-year-old graphic designer, moved from California to Texas mid-claim; her file transferred to Texas DDS under POMS DI 11010.001, and the new agency completed the case in seven weeks.

Recap of Key Rulings and Precedents

Several rulings and precedents shape how DDS reads SSA-4814. SSR 23-1p governs symptom evaluation and instructs adjudicators to consider the consistency of statements with the medical evidence, including the form. SSR 16-3p remains the predecessor authority on subjective symptoms and is cited in older files.

The Supreme Court’s decision in Sullivan v. Zebley, 493 U.S. 521 (1990) established that medical equivalence must be considered, which is why Item 8 of SSA-4814 matters even when the listing is not strictly met. The Ninth Circuit in Garrison v. Colvin, 759 F.3d 995 (2014) reinforced that treating-source opinions, when supported and consistent, deserve significant weight, a principle preserved in spirit under the post-2017 rules at 20 CFR 404.1520c.

The Eighth Circuit in Reed v. Barnhart, 399 F.3d 917 (2005) emphasized that the agency must develop the record fully, which underlies SSA’s duty to send SSA-4814 to providers when claimants cannot. The consequence of these rulings is that a well-completed form is both the claimant’s best evidence and the agency’s best defense against remand.

Filing, Submission, and Follow-Up

Submit the completed form through the SSA’s electronic Records Express portal, by fax to the assigned DDS office, or by mail with a cover letter referencing the claim number. Keep a stamped copy and confirm receipt within ten days, because lost forms are a frequent cause of delay. The consequence of failing to confirm is that the deadline for evidence under the five-day rule at 20 CFR 404.935 at hearing level can pass without notice.

A real example: Sergio, a 51-year-old line cook, faxed his form on a Friday afternoon and called DDS the following Tuesday to confirm; the early follow-up caught a missing page and avoided a denial. A common misconception is that electronic submission guarantees receipt; it does not, and verification is always the safer practice.

FAQs

Is Form SSA-4814 mandatory for HIV disability claims?

No. It is the preferred form, but SSA accepts equivalent medical source statements that contain the same data points, lab values, and functional findings required under Listing 14.11.

Can a nurse practitioner sign Form SSA-4814?

Yes. For claims filed on or after March 27, 2017, advanced practice registered nurses and physician assistants are acceptable medical sources under 20 CFR 404.1502 and may sign the form.

Does an undetectable viral load disqualify a claimant?

No. Functional limitations, side effects, opportunistic infection history, and CD4 nadir can still support approval under Listing 14.11I or through medical-vocational rules.

Will SSA pay the doctor for completing the form?

Yes. SSA reimburses providers a modest fee under 20 CFR 404.1624 when DDS requests the form, but the rate varies by state and is often below private-practice charges.

Can a claimant fill out parts of Form SSA-4814 themselves?

No. Only an acceptable medical source may complete the medical content, and claimant-completed sections are disregarded as treating-source evidence.

Does CD4 count alone determine approval?

No. SSA evaluates CD4 alongside opportunistic infections, viral load, treatment response, side effects, functional limitations, and co-occurring impairments before deciding.

Is HIV automatically a disability under SSA rules?

No. HIV is a recognized impairment, but the claimant must still meet the listing, equal a listing, or be unable to perform substantial gainful activity under the sequential evaluation.

Can the form be submitted electronically?

Yes. SSA’s Electronic Records Express accepts the signed PDF, but the signature must be authenticated and the file size must comply with portal limits.

Does Form SSA-4814 expire?

Yes. SSA generally treats medical evidence older than 90 days as needing update at the initial level, and DDS may request a refreshed form before deciding.

Will completing SSA-4814 guarantee approval?

No. A complete form maximizes the chance of approval, but DDS still applies the five-step sequential evaluation in 20 CFR 404.1520 and considers vocational factors at steps four and five.

Can the form be used for SSI as well as SSDI?

Yes. The same form supports Title II SSDI claims and Title XVI SSI claims, because both programs use identical medical criteria under 20 CFR 416.913 and 20 CFR 404.1513.

Is HIV-associated neurocognitive disorder evaluated on SSA-4814?

Yes. Item 6 captures cognitive limitations, and HAND is also evaluated under Listing 12.02 for neurocognitive disorders when the symptoms are severe.